Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Tips for Diagnosing Metabolic Myopathies

Ruth Jessen Hickman, MD  |  Issue: September 2019  |  September 17, 2019

Referral & Ongoing Care

Although rheumatologists are typically comfortable with the diagnosis and treatment of inflammatory myopathies, if a metabolic myopathy is suspected, referral to a metabolic neurologist is indicated. There, more specialized diagnostic tests can be performed. If a rheuma­tologist has strong clinical suspicion of a structural myopathy, referral to a neuromuscular neurologist would also be prudent. In both cases, these specialists may be better suited performing some of the specific, second-line tests involved in diagnosing these rare conditions.

Dr. Tarnopolsky recommends patients diagnosed with metabolic myopathies be treated at a specialty center in a major academic institution, because the treatment is highly disease specific, and new treatments are always emerging. A few of the metabolic myopathies have established specific treatments, such as enzyme replacement therapy for Pompe disease or riboflavin for MADD (multiple acyl-CoA dehydrogenase deficiency). Specially tailored exercise therapy also seems to benefit many patients, and depending on the condition, specific dietary plans can help.4,5

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

But for the most part, treatment centers on helping patients avoid disease triggers and prevent rhabdomyolysis. Rheumatologists can play an important role in identifying the patients at risk of this potential serious complication due to an undiagnosed metabolic myopathy.


Ruth Jessen Hickman, MD, is a graduate of the Indiana University School of Medicine. She is a freelance medical and science writer living in Bloomington, Ind.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. van Adel BA, Tarnopolsky MA. Metabolic myopathies: Update 2009. J Clin Neuromuscul Dis. 2009 Mar;10(3):97–121.
  2. Berardo A, DiMauro S, Hirano M. A diagnostic algorithm for metabolic myopathies. Curr Neurol Neurosci Rep. 2010 Mar;10(2):118–126.
  3. Olpin SE, Murphy E, Kirk RJ, et al. The investigation and management of metabolic myopathies. J Clin Pathol. 2015 Jun;68(6):410–417.
  4. Tarnopolsky MA. Metabolic myopathies. Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):1829–1851.
  5. Finsterer J. An update on diagnosis and therapy of metabolic myopathies. Expert Rev Neurother. 2018 Dec;18(12):933–943.
  6. Quinlivan R, Jungbluth H. Myopathic causes of exercise intolerance with rhabdomyolysis. Dev Med Child Neurol. 2012 Oct;54(10):886–891.
  7. Smith BW, McCarthy JC, Dawley CA. Suspect myopathy? Take this approach to the work-up. J Fam Pract. 2014 Nov;63(11):631–638.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Conditions Tagged with:creatinine kinesegenetic diseasegenetic disordersMetabolic Myopathiesrhabdomyolysis

Related Articles

    Diagnosis: Myopathy

    July 1, 2009

    Presentation and evaluation of metabolic causes

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Fellows’ Forum Case Report: Necrotizing Autoimmune Myopathy

    December 18, 2017

    Necrotizing autoimmune myopathy (NAM) is a relatively recently discovered subgroup of inflammatory myopathies. NAM is characterized by predominant muscle fiber necrosis and regeneration with little or no inflammation.1 One subgroup of NAM is 3-hydroxy-3-methylglutaryl-CoA reductase antibody (HMGCR Ab)-related immune-mediated necrotizing myopathy (IMNM), which occurs (rarely) after statin exposure, with a rough incidence of two per…

    Myositis Mysteries

    January 1, 2008

    Why isn’t my myositis patient getting better?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences